Cancer group calls for information on genotype and diet-related disease

By Mike Stones

- Last updated on GMT

The National Cancer Institute’s Nutritional Science Research Group has issued a Request for Information to help plan human studies designed to reveal the relationship between genotype and diet-related cancer prevention.

The Request for Information (RFI) is to help prioritize “well-designed dietary intervention trials to investigate nutrigenetics ​(or the relationship between genotype and diet-related disease) as a determinant of the response to bioactive food components and to evaluate their utility as biomarkers for predicting risk and/or tumor behavior​,” according to a statement issued by the National Institutes of Health (NIH​) and National Cancer Institute (NCI​).

Diet-sensitive

The research group is particularly interested in studying: Diet-sensitive genetic modifications that warrant further focus for potential intervention studies, nutrient, bioactive food components from foods or supplements, specific cancer process related genes with molecular targets that are diet-sensitive and critical issues that are limiting investigation.

It has invited responses from: Academics, small businesses, pharmaceutical/biotechnology companies, health care professionals, patient advocacy groups and Federal and State Government.

Responses should be directed to Nancy Emenaker, program director, Nutritional Science Research Group (rzranxra@znvy.avu.tbi​) and should arrive by April 15, 2011.

Meanwhile, the statement recognized “…increasing evidence points to diet as a modifier of cancer risk and tumor behavior. Numerous bioactive food components may be involved in bringing about these responses​.”

Predictive insights

But the literature is filled with many inconsistencies, it pointed out. “Genetic variants involved with absorption, metabolism and/or excretion of specific food components and their associated molecular targets may provide valuable predictive insights into human response to foods and dietary supplements​.”

The scientific literature suggests incorporating information on genetic variations involved with absorption, metabolism and/or excretion processes may help to predict which individuals are likely to benefit most by dietary modification.

The NCI said that it did not intend to make any awards based on responses to this RFI or to otherwise pay for the preparation of any information submitted or for the Government's use of such information.

Related news

Related products

show more

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

LocVita® Natural Vitamin E Acetate 950IU Beadlets

LocVita® Natural Vitamin E Acetate 950IU Beadlets

Content provided by INNOBIO Corporation Limited | 20-Sep-2024 | White Paper

Incorporating double-layer encapsulation technology, LocVita® Natural Vitamin E Acetate 950IU Beadlets demonstrate improved stability and pressure resistance.

Your guide to nutritional care innovation

Your guide to nutritional care innovation

Content provided by dsm-firmenich | 20-Aug-2024 | Insight Guide

The medical nutrition market is primed for innovation due to aging populations, chronic diseases, nutrition awareness and scientific advances. Our comprehensive...

Related suppliers

Follow us

Products

View more

Webinars